{
    "Trade/Device Name(s)": [
        "Optilite IgA CSF Kit"
    ],
    "Submitter Information": "The Binding Site Group, Ltd.",
    "510(k) Number": "K183151",
    "Predicate Device Reference 510(k) Number(s)": [
        "K993549"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFN"
    ],
    "Summary Letter Date": "November 6, 2018",
    "Summary Letter Received Date": "November 14, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, and E immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "IgA"
    ],
    "Specimen Type(s)": [
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Optilite analyser"
    ],
    "Method(s)/Technology(ies)": [
        "Quantitative immunoturbidimetry",
        "Turbidimetric"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Calibrator",
        "Control",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for Optilite IgA CSF Kit, a turbidimetric assay for quantitative measurement of IgA in cerebrospinal fluid using the Optilite analyser",
    "Indications for Use Summary": "Intended for quantitative in vitro measurement of IgA in cerebrospinal fluid (CSF) using the Optilite analyser",
    "fda_folder": "Immunology"
}